Trenchant, I am not a contrarian or a mole just another shareholder expressing my point of view without name calling or anger. I have heard quite a bit of communication complaining about PR, which is actually a form of marketing. I did not want to stir up anger, but watching reckless money (considerable) going to big companies without a proven product I believe a significant amount is coming from institutional investors. As the science becomes in the consumable public domain. I just think the playing field will change. I am in no way advocating a LBO, but as an investor I am preparing myself. My thoughts could be wrong, I just wanted to share. How do other members feel about the upcoming type A meeting, 30% of the FDA's operating expense comes from big Pharma, with even some members having significant connections to those corporations. Absolutely nothing I support! But, I believe could pose a significant obstacle.